FDA revises IEM drug draft guidance to clarify food standards, use of control groups
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesClinical TrialsNorth AmericaPharmaceuticalsRegulatory NewsFerdous Al-FaruqueBiologics/ biosimilars/ vaccinesClinical TrialsNorth AmericaPharmaceuticals